|
State of Florida Brain Bank - Searching for the Answers (Protocol #97-82-H-11)
Brain Donation is one very important way of confirming the diagnosis of Alzheimer's disease or other forms of dementia. Brain Donation is crucial for learning more about how to diagnose and treat Alzheimer's disease. If someone near and dear to you has been diagnosed to have Alzheimer's disease or memory problems, the State of Florida Brain Bank can make all the arrangements to facilitate donation of the brain for confirming the diagnosis and for research. Individuals who are in the earliest stages of Alzheimer's Disease, and those with a pre-Alzheimer condition known as Mild Cognitive Impairment are particularly important for this research. Normal brain tissue, for comparison purposes is difficult to get but is also very important for research. Individuals who are over the age of 65 and have normal memory can donate their brains for research through this program, after getting a comprehensive neurological examination and an MRI scan of the brain.
For those who participate in this study:
- At the time of death we will arrange for the transportation and removal of the brain, at no cost.
- We will provide a detailed pathological report, at no cost to you.
If you have any further questions or need more details about this study, please call our studies coordinator Yirah at 305-674-2018
Memory Screening Studies on Healthy Aging (Protocol #01-61-H-08)
Are you worried that your memory is not what it used to be? Take advantage of a free memory screening to determine if further evaluation is needed. Participants must be at least 60 years of age. Screenings are available at:
Mount Sinai Medical Center
4300 Alton Road
Miami Beach, FL 33140
Limited space · By appointment only · Please call 305-674-2435
Has your family member or loved one been diagnosed with Alzheimer's Disease (Protocol #08-49-H-11)
If so, he/she may be eligible to participate in a nationwide Clinical Research Trial investigating a new type of medication aimed at slowing or stopping disease progression. Current medications prescribed by doctors can only manage the symptoms of Alzheimer's, but not alter the disease course.
For more information or for an appointment
call Mount Sinai Medical Center - Wien Center at 305-674-2435
and ask for "Ms. Vazquez"
Participants can continue taking all their currently prescribed medications. All study-related medications, exams and office visits are provided free of charge. (Further compensation may also be available for time, travel and meals.)
Exercise Versus Cognitive Interventions for Elders at Risk for Dementia (Protocol #09-39-H-10)
Are you worried that your memory is not what it used to be? If you are at least 65 years of age, you may qualify for a study to determine if physical and/or mental exercises can improve your memory, thinking and everyday functioning skills.
If you are interested in finding out more about this study, please call (305) 674-2543 and ask for Celeste.
Alzheimer's Disease Neuroimaging Protocol Grand Opportunity - ADNI-GO
(Protocol #10-03-H-01)
Do you want to participate in a study to look at the usefulness of brain scans, markers in your blood and spinal fluid, together with measurements of memory, thinking and daily functioning, in the identification and treatment of Alzheimer's Disease at an early stage.
This study is sponsored by the National Institute on Aging. The Wien Center will be one of over 50 clinical centers participating in the study. You may qualify for this study if you are in good general health, have very mild memory problems and are between 50 and 89 years of age.
If you qualify, you will have to come to the Wien Center for 5 visits to test your memory and to have several different types of brain scans, including an MRI and a PET scan. Also, blood will be drawn from a vein in your arm and spinal fluid will be drawn from your back. You will be reimbursed for your time.
For more information, please contact Peggy at (305) 674-2424 or a proberts@msmc.com.
A Principal Open-label Study to Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects with Amnestic Mild Cognitive Impairment Who Will Convert to Probable Alzheimer's Disease (Protocol #10-09-H-04)
Do you want to participate in a study to determine if a Positron Emission Tomography (PET) brain scan using a new radioactive compound can assist physicians in the early diagnosis of Alzheimer's Disease?
This study is sponsored by GE Healthcare. The Wien Center will be one of the 20 clinical centers participating in the study. You may qualify for this study if you are in good general health, are 60 years of age or older, have memory problems, but can still function independently. If you qualify, you will be given a complete physical exam and a PET scan using this new compound.
For more information, please contact Peggy at (305) 674-2424 or a proberts@msmc.com.
|
